{"id":"https://genegraph.clinicalgenome.org/r/86d93d1c-2164-45e3-a8f4-4470567f3d9dv1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between MT-TW and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of May 17, 2021. The MT-TW gene encodes the mitochondrial transfer RNA (tRNA) for tryptophan. Defects of this tRNA lead to impaired mitochondrial translation, which leads to decreased synthesis of mtDNA-encoded subunits of oxidative phosphorylation (OXPHOS) complexes I, III, IV, and V and thus impaired OXPHOS enzyme activities.\n\nThe MT-TW gene was first reported in relation to maternally inherited Leigh syndrome in 1997 (PMID: 9266739). Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included 2 variants in 3 cases (1 with m.5559A>G, 2 with m.5537_5538insT) from 3 publications (PMIDs: 9266739, 26524491, 12776230). Segregation information is scored as case level evidence according to the criteria established by the Mitochondrial Disease Gene Curation Expert Panel. Loss of function is implicated as the mechanism of disease. This gene-disease association is also supported by known biochemical function (PMID: 27977873). \n\nIn summary, there is limited evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on May 17, 2021 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/86d93d1c-2164-45e3-a8f4-4470567f3d9d","GCISnapshot":"https://genegraph.clinicalgenome.org/r/3dc54202-27f3-4bf4-883f-5273a49dcb70","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/3dc54202-27f3-4bf4-883f-5273a49dcb70_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2021-06-28T15:05:50.120Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/3dc54202-27f3-4bf4-883f-5273a49dcb70_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2021-06-28T15:05:59.313Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3dc54202-27f3-4bf4-883f-5273a49dcb70_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3dc54202-27f3-4bf4-883f-5273a49dcb70_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e0ace9a-81ca-4c89-95b7-223c2557f38e","type":"EvidenceLine","dc:description":"per rubric: More than 10 genes with a related function","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac15bbd6-c894-4a7b-825c-14a15f0a4424","type":"Finding","dc:description":"Rahman et al. reviews all genes associated with Leigh syndrome in Leigh Map 2017 (PMID: 27977873). These genes included at least thirteen nuclear genes directly involved in mitochondrial translation as well as five additional mt-tRNA genes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27977873","rdfs:label":"Review: LeighMap","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3dc54202-27f3-4bf4-883f-5273a49dcb70_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3dc54202-27f3-4bf4-883f-5273a49dcb70_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/decf836e-9ab3-44b3-be09-af26c762ddd2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The proband showed 43% heteroplasmy (tissue not given), the maternal sample showed 23% heteroplasmy (tissue not given). SCORE 0. At the GCEP review the consensus was not to count this case, insufficient evidence. ","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b56e95c6-f364-4107-80dd-07607fc0e851","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19349200","rdfs:label":"P10","ageType":"AgeAtReport","ageUnit":"Years","ageValue":12,"detectionMethod":"sequenced the encoded complex I units: tRNAVal, tRNALeu(UUR), tRNATrp ND2, ND3, ND4, ND5 and ND6 genes and the mitochondrial ATPase 6, and tRNALys. ","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Diagnosed with leigh syndrome, First symptoms observed at the age of 9 years. Psychomotor delay, MRI showed symmetric hyperintense signal involving the head of the caudate nucleus, the putamen. Vomiting, lactate acidosis\nLactate CSF 4.8mmol/l","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/decf836e-9ab3-44b3-be09-af26c762ddd2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19349200","allele":{"id":"https://genegraph.clinicalgenome.org/r/41097e83-0646-4558-b23d-698814719283","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_012920.1:m.5559A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345913"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria"},{"id":"https://genegraph.clinicalgenome.org/r/683102da-65d5-4c02-a86b-d51999420321_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The variant was homoplasmic in the blood of the proband and the two affected siblings. It was also homoplasmic in the liver of II-1 and the fibroblasts of II-3 (Sanger and pyrosequencing). The variant was found at a 70% heteroplasmy in the blood of the healthy mother. The variant was not found in a homoplasmic state in individuals from gnomAD, there was 1 heteroplasmic carrier (36%). Mixed in silico predictions: MitoTip 15.5 (&0%) Possibly pathogenic, PON-mt-tRNALikely neutral (0.399), HmtVarLikely Polymorphic (0.250). Fibroblasts derived from patient II-3 showed a significant loss of the mature tRNATrp and enrichment in the unprocessed polycistronic transcript containing this tRNA by northern blot (Fig 2A) 35S-labeled de novo incorporation of methionine and cysteine into mitochondrial DNA encoded proteins showed an overall decrease in mitochondrial protein synthesis in patient cells, immunoblot showed a decrease in the abundance of MTDNA genes encoding OXPHOS complexes (3B) Mitochondrial oxygen consumption was measured in digitonin-permeabilized, oxygen consumption from substrates entering at complexes I, III and IV was significantly lowered when compared to control cells (Fig. 4) SCORE: 1pt (0.5 segregation of heteroplasmy, 0.5 functional data).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc9ce4f6-a402-4189-a99c-cb80e4fff5c8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26524491","rdfs:label":"Patient II-1 (Proband)","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"detectionMethod":"Next generation sequencing of the mitochondrial genome","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Family History: The affected family members are two males and one female with different fathers. The mother, who is heteroplasmic for the identified mutation, is clinically unaffected.  \nThe proband had IUGR, and was born prematurely at 34 weeks with failure to thrive. He had cholestatic jaundice and progressive hepatosplenomegaly from birth.\nThere was global developmental delay, especially in the area of speech. Neuropsychometric testing placed his intellectual functioning at the extremely low range. At 8 years of age there is an absence of speech.\nBlood lactate levels were elevated to a maximum of 4.1 mmol/L.\nBrain MRI at 10 weeks showed oedema within the parietal and occipital white matter and increased lactate peak in the basal ganglia (Fig. 1Aâ€“C). A further MRI of the brain aged 3 years showed an increased T2 signal within the white matter bilaterally and increased bilateral thalamic signal, corresponding with lactate peaks on MR spectroscopy (MRS).\nRespiratory enzyme analysis of liver tissue indicated low activity of complexes I, III and IV (Supplementary Table 1).\n\nAffected male sibling Patient II-3  showed a similar phenotype. Hypertrophic cardiomyopathy was also diagnosed at 3 years of age. Respiratory enzyme analysis of liver and muscle tissue indicated low activity of complexes I, III and IV.\nAffected female sibling showed a similar severe phenotype","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/683102da-65d5-4c02-a86b-d51999420321_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26524491","allele":{"id":"https://genegraph.clinicalgenome.org/r/41097e83-0646-4558-b23d-698814719283"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9c6d434a-0852-49e4-b1e2-cb3de3fe792d_proband_score_evidence_line","type":"EvidenceLine","dc:description":"not found in gnomAD, Mitotip N/A 97.78% conservation.      The proband showed >95% heteroplasmy in blood, liver, muscle of patient. The proband's mother showed 81% heteroplasmy in blood. The skeletal muscle biopsy of the proband showed COX deficiency and complex I deficiency. SCORE: 0.5  (heteroplasmy segregation)\n","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80e96631-9422-4bbc-af97-ba0b48214c48","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12776230","rdfs:label":"Case report Tulinius 2003","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"detectionMethod":"mtDNA sequencing","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"The proband had a normal birth and birth weight, but regression was noted from 5 months and  early developmental milestones were delayed, there were recurrent episodes of fever, irritability and hypotonia, increased tone in lower extemities and nystagmus was noted on a first hospitalization at 8 months. Liver biopsy showed steatosis, fibrosis and abnormal mitochondria. Tonic clonic seizures were reported at 14 months, At  2 years the proband had severe ID and optic atrophy. The progressive clinical course, characterized by episodes of hyper and hypothermia, recurrent respiratory tract infections, generalized seizures, severe GI problems, vomiting and swallowing difficulties. \n\nIncreased lactate in blood (2.6-8.8 mmol/l, CSF and urine.\nCT scan at 8 months: symmetrical lesion pattern involving cortico-spinal tracts, frontal and dorsal symmetrical hypodensities. \nMRI at 2 years, 8 months(Fig 2a-c) showed hyperintense signal in the anterior pons. (see text for complete description)\n\nFamily history included the 5th sister of the mother and  2 of 4 children who were diagnosed with LSS, data not shown. ","previousTesting":true,"previousTestingDescription":"direct sequencing of SURF1, SCO2, COX17","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/9c6d434a-0852-49e4-b1e2-cb3de3fe792d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12776230","allele":{"id":"https://genegraph.clinicalgenome.org/r/6172debf-e874-4cad-abdc-c6bc8850e722","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"m.5537_5538insT","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA120541"}},"paternityMaternityConfirmed":"none"},{"id":"https://genegraph.clinicalgenome.org/r/1c547d64-7d14-4660-b3a7-3f7da482e473_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12776230","allele":{"id":"https://genegraph.clinicalgenome.org/r/6172debf-e874-4cad-abdc-c6bc8850e722"},"paternityMaternityConfirmed":"none"}]}],"specifiedBy":"GeneValidityProbandADNonNullCriteria"},{"id":"https://genegraph.clinicalgenome.org/r/8afe7557-6f39-49aa-8786-bd66f07dc1cd_proband_score_evidence_line","type":"EvidenceLine","dc:description":"not found in gnomAD, Mitotip N/A 97.78% conservation. The proband muscle was >95% heteroplasmic for the variant, >95% in all autopsied tissues >98% in brain regions. The affected male sibling showed >92% blood, affected female sibling 89% blood, Patient III-1 Mother, 75% blood, Patient III-2 Aunt 78% blood, Patient II- 1 MGM 42% blood. SCORE: 0.5 (for segregation of heteroplasmy)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0bfc4201-b8f7-442f-a068-e4d1bfe7c9ae","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9266739","rdfs:label":"Patient IV-2","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":10,"detectionMethod":"MT-DNA genes were screened by direct sequencing","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"The Patient IV-2 (was healthy at birth but lost milestones around the age of 10 months following his third DPT immunization and fever. Within 2 weeks, swallowing difficulties developed. At the age of 14 months, he became blind and motor skills had regressed; he was no longer able to sit or crawl. The blood lactate level was elevated (3.2 mmol/liter). Brain MRI findings were consistent with deep\nwhite matter disease. He died suddenly at the age of 17 months because of cardiorespiratory arrest. Autopsy showed extensive subcortical pathology and prominent involvement of the thalamic nuclei, consistent with LS.\n\nPatient IV-2 at the age of 4 years  began developing a difficulty of seeing objects on the floor, At the age of 6 years, neurological evaluation showed impaired visual acuity (20/80 in each eye), slight optic disc pallor, and mild difficulty balancing on one foot. Parents reported poor performance in school. Brain (MRI) showed bilateral hyperintensities in the periatrial white matter and in the splenium of the corpus callosum. mildly elevated arterial lactate value (2.3 mmol/liter, normal < 1.8 mmol/liter). Muscle biopsy: 11% complex IV, 43% complex I+II, 47% complex I\n\nPatient IV-3 16 month female at report, mild temporal pallor in the right eye and mild incoordination, elevated lactate, Brain MRI showed bilateral T2-weighted hyperintensities in the basal ganglia.\n\nPatient III-1 Mother, She had medical complaints since adolescence, including major depression, irritable bowel, and migraine-like headaches. Normal lactate and MRI\n\nPatient III-2 19 year half sister of mother, depression\nPatient II- 1 MGM depression\nPatient I-I MGGM depression","previousTesting":true,"previousTestingDescription":"common mtDNA mutations A8344G, T8356C, A3243G, A3271G, T8993G, and T8993C, as well as the pathogenic mtDNA mutations associated with LHON (nucleotides 3460, 4 160,\n11778, 13708, and 15257), were all ruled out. ","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8afe7557-6f39-49aa-8786-bd66f07dc1cd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9266739","allele":{"id":"https://genegraph.clinicalgenome.org/r/6172debf-e874-4cad-abdc-c6bc8850e722"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1c547d64-7d14-4660-b3a7-3f7da482e473_proband_score_evidence_line","type":"EvidenceLine","dc:description":"not found in gnomAD, Mitotip N/A 97.78% conservation, the proband showed >95% heteroplasmy in blood, liver, muscle of patient. The proband's mother showed 81% heteroplasmy in blood. The skeletal muscle biopsy of the proband showed COX deficiency and complex I deficiency. SCORE: 0.5 (heteroplasmy segregation)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80e96631-9422-4bbc-af97-ba0b48214c48"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Limited","sequence":3041,"specifiedBy":"GeneValidityCriteria8","strengthScore":4,"subject":{"id":"https://genegraph.clinicalgenome.org/r/fOPyGEqmrG0","type":"GeneValidityProposition","disease":"obo:MONDO_0009723","gene":"hgnc:7501","modeOfInheritance":"obo:HP_0001427"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_3dc54202-27f3-4bf4-883f-5273a49dcb70-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}